Personalized health risk assessment based on single-cell RNA sequencing analysis of a male with 45, X/48, XYYY karyotype
Magdalena Koczkowska,Marcin Jąkalski,Dorota Birkholz-Walerzak,Anna Kostecka,Mariola Iliszko,Magdalena Wójcik,Krzysztof Lewandowski,Katarzyna Milska-Musa,Patrick G Buckley,Kinga Drężek,Ulana Juhas,Ewa Kuziemska,Agnieszka Maciejewska,Ryszard Pawłowski,Bartosz Wasąg,Natalia Filipowicz,Katarzyna Chojnowska,Urszula Ławrynowicz,Jan P Dumanski,Beata S Lipska-Ziętkiewicz,Jakub Mieczkowski,Arkadiusz Piotrowski
DOI: https://doi.org/10.1038/s41598-022-25308-w
2022-12-02
Abstract:Numeric sex chromosome abnormalities are commonly associated with an increased cancer risk. Here, we report a 14-year-old boy with a rare mosaic 45, X/48, XYYY karyotype presenting with subtle dysmorphic features and relative height deficiency, requiring growth hormone therapy. As only 12 postnatal cases have been described so far with very limited follow-up data, to assess the proband's long-term prognosis, including cancer risk, we performed high-throughput single-cell RNA sequencing (scRNA-seq) analysis. Although comprehensive cytogenetic analysis showed seemingly near perfect balance between 45, X and 48, XYYY cell populations, scRNA-seq revealed widespread differences in genotype distribution among immune cell fractions, specifically in monocytes, B- and T-cells. These results were confirmed at DNA level by digital-droplet PCR on flow-sorted immune cell types. Furthermore, deregulation of predominantly autosomal genes was observed, including TCL1A overexpression in 45, X B-lymphocytes and other known genes associated with hematological malignancies. Together with the standard hematological results, showing increased fractions of monocytes and CD4+/CD8+T lymphocytes ratio, long-term personalized hemato-oncological surveillance was recommended in the reported patient.